Cancer Moonshot℠ - Obligations by Budget Mechanism

With $300 million appropriated for Cancer Moonshot activities in fiscal year (FY) 2018, funding was allocated into four budget mechanisms: research grants, R&D contracts, intramural research, and research management and support, as shown in the chart below.

Download Table Data

Similar to the institute’s annual appropriation, NCI reports Cancer Moonshot obligations by funding mechanism.

FY 2018 Cancer Moonshot and Carryover - Obligations by Mechanism
 (Whole Dollars)
Type of Mechanism Mechanism Number Amount
Research Project Grants (RPGs) Competing 26 $59,520,038
Noncompeting 20 $22,300,821
Administrative Supplements 31 $4,421,709
Subtotal, without SBIR 46 $86,242,568
SBIR/STTR Grants 7 $4,367,647
Subtotal, RPGs 53 $90,610,215
Centers
Cancer Centers Grants-P30s 0 $10,954,951
Cooperative Agreements-U54s/U41s 11 $61,079,470
Subtotal, Centers 11 $72,034,421
Other Research Resource Grants-U24s/U2Cs 15 $93,173,756
Subtotal, Other Research 15 $93,173,756
Subtotal, Research Grants   79 $255,818,392
Intramural Research 0 $4,034,821
Research Management & Support 0 $45,222
R&D Contracts R&D Contracts 7 $38,802,916
SBIR/STTR Contracts 21 $6,410,821
Subtotal, R&D Contracts 28 $45,213,737
Total
$305,112,172
 Includes FY 2017 Cures-Moonshot Carryover obligations.
  • Posted: December 20, 2018